The Carlyle Group L.P. Stock News

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturd

The company said that this fresh growth investment into its Pharma Business will be used as growth capital for the pharma businesses.

The estimated equity capital investment for Carlyle's 20 per cent stake in Piramal Pharma would amount to around $490 million.

The transaction values the pharma business at an enterprise value of $2.78 billion, with an upside component of up to $360 million depending on the company’s FY21 performance

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturd

Carlyle Group will purchase a 20% stake in Indian billionaire Ajay Piramal’s pharmaceutical business, according to an exchange filing.

(Bloomberg) -- Carlyle Group will purchase a 20% stake in Indian billionaire Ajay Piramal’s pharmaceutical business, according to an exchange filing.The private equity fund will pay $490 million for

The CEO of Nasdaq led the exchange’s seamless transition to remote operation.

Money was raised via issuance of three-year NCDs at a rate of 9% to Farallon Capital.PiramaL group has taken several steps in the past six months to manage its liquidity

Carlyle buys 20% stake in Piramal Pharma businesses

They are able to identify the economic benefit of focusing on solving ESG issues.

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen

Keysight Technologies has acquired digital automation company Eggplant from The Carlyle Group for $330 million. Keysight described Eggplant as a “software test automation platform provider th…